首页|胃苏颗粒联合泮托拉唑对非萎缩性胃炎患者胃肠激素及血清MCP-1、EGF的影响

胃苏颗粒联合泮托拉唑对非萎缩性胃炎患者胃肠激素及血清MCP-1、EGF的影响

扫码查看
目的 探讨胃苏颗粒联合泮托拉唑对非萎缩性胃炎患者胃肠激素及血清单核细胞趋化因子-1(MCP-1)、表皮生长因子(EGF)的影响.方法 选取2020年1月~2023年1月在我院就诊的非萎缩性胃炎患者116例,按照随机数字表法分为观察组和对照组,每组58例.对照组给予泮托拉唑20mg,2次/d,连续4周;观察组在对照组基础上加用胃苏颗粒5g,3次/d,连续4周.比较两组患者治疗前后胃肠激素(胃泌素、胆囊收缩素、生长抑素、血清素)及血清MCP-1、EGF的水平变化,以及临床疗效和不良反应.结果 治疗后,两组患者的胃泌素和生长抑素水平明显升高,胆囊收缩素和血清素水平明显降低(P<0.001);血清MCP-1水平明显降低、EGF水平明显升高,两组相比差异有统计学意义(P=0.007、0.008).治疗后观察组的临床症状总分低于对照组(P<0.001).观察组的总有效率为93.10%,显著高于对照组(74.14%),差异有统计学意义(P=0.009).两组患者均未出现严重不良反应.结论 胃苏颗粒联合泮托拉唑能够有效调节非萎缩性胃炎患者的胃肠激素及血清MCP-1、EGF水平,改善胃黏膜的修复和保护功能,提高临床疗效,安全性好.
Effect of Weisu Granules combined with pantoprazole on gastrointestinal hormones and serum MCP-1,EGF in patients with non-atrophic gastritis
Objective To investigate the effect of Weisu granules combined with pantoprazole on gastrointestinal hormones,serum monocyte chemoattractant protein-1(MCP-1),and epidermal growth factor(EGF)in patients with non-atrophic gastritis.Methods A total of 116 patients with non-atrophic gastritis who were treated in our hospital from January 2020 to January 2023 were ran-domly divided into observation group and control group,with 58 patients in each group.The control group received pantoprazole 20mg twice daily for 4 weeks.The observation group received additional Weisu granules 5g three times daily for 4 weeks.The levels of gastrointestinal hormones(gastrin,cholecystokinin,somatostatin,serotonin),serum MCP-1,and EGF were compared before and after treatment.Clinical efficacy and adverse reactions were also compared.Results After treatment,the levels of gastrin and somatostatin in both groups significantly increased,while the levels of cholecysto-kinin and serotonin significantly decreased(P<0.001).The serum levels of MCP-1 significantly de-creased and the levels of EGF significantly increased,with significant differences between the two groups(P=0.007 and 0.008).The total clinical symptom score in the observation group was lower than that in the control group after treatment(P<0.001).The total effective rate was 93.10%in the observation group,which was significantly higher than that in the control group(74.14%)(P=0.009).No serious adverse reactions were observed in either group.Conclusion Weisu granules com-bined with pantoprazole can effectively regulate the levels of gastrointestinal hormones,serum MCP-1,and EGF in patients with non-atrophic gastritis,improve the repair and protective function of gas-tric mucosa,improve clinical efficacy,and have good safety.

Non-atrophic gastritisWeisu granulesPantoprazoleGastrointestinal hormonesMonocyte chemoattractant protein-1Epidermal growth factor

张莉莉、王方方、王艳晖、张飞娟、马建平

展开 >

平顶山市第一人民医院消化内科二病区 河南平顶山 467000

平顶山市第一人民医院急诊科 河南平顶山 467000

非萎缩性胃炎 胃苏颗粒 泮托拉唑 胃肠激素 单核细胞趋化因子-1 表皮生长因子

2024

华北理工大学学报(医学版)
河北联合大学

华北理工大学学报(医学版)

影响因子:0.569
ISSN:2095-2694
年,卷(期):2024.26(1)
  • 18